KRAS and colorectal cancer: Cetuximab is a recombinant mouse/human chimeric monoclonal antibody that targets EGFR to treat patients with EGFR- and wild-type Kirsten rat sarcoma 2 viral oncogene homolog (KRAS)-expressing colorectal cancer [168].